Published in Am J Epidemiol on April 15, 2002
Nicotine from edible Solanaceae and risk of Parkinson disease. Ann Neurol (2013) 2.08
Atypical cancer pattern in patients with Parkinson's disease. Br J Cancer (2005) 1.72
Premotor Parkinson's disease: concepts and definitions. Mov Disord (2012) 1.70
Polyphenols and human health: prevention of disease and mechanisms of action. Nutrients (2010) 1.66
The neuroprotective potential of flavonoids: a multiplicity of effects. Genes Nutr (2008) 1.61
Environmental risk factors for Parkinson's disease and parkinsonism: the Geoparkinson study. Occup Environ Med (2007) 1.60
Neurodegenerative diseases: an overview of environmental risk factors. Environ Health Perspect (2005) 1.30
Genetics of caffeine consumption and responses to caffeine. Psychopharmacology (Berl) (2010) 1.27
Occupational factors and risk of Parkinson's disease: A population-based case-control study. Am J Ind Med (2010) 1.26
Increased risk of parkinsonism associated with welding exposure. Neurotoxicology (2012) 1.23
Differential effects of black versus green tea on risk of Parkinson's disease in the Singapore Chinese Health Study. Am J Epidemiol (2007) 1.15
Gene-environment interactions: key to unraveling the mystery of Parkinson's disease. Prog Neurobiol (2011) 1.14
Tobacco smoking and disability progression in multiple sclerosis: United Kingdom cohort study. Brain (2013) 1.14
Pathophysiological roles for purines: adenosine, caffeine and urate. Prog Brain Res (2010) 1.13
Validity and reliability of an occupational exposure questionnaire for parkinsonism in welders. J Occup Environ Hyg (2009) 1.12
Neuroprotective molecular mechanisms of (-)-epigallocatechin-3-gallate: a reflective outcome of its antioxidant, iron chelating and neuritogenic properties. Genes Nutr (2009) 1.12
Tea and health: studies in humans. Curr Pharm Des (2013) 1.10
Dietary polyphenols as modulators of brain functions: biological actions and molecular mechanisms underpinning their beneficial effects. Oxid Med Cell Longev (2012) 1.08
Glyceraldehyde-3-phosphate dehydrogenase-monoamine oxidase B-mediated cell death-induced by ethanol is prevented by rasagiline and 1-R-aminoindan. Neurotox Res (2009) 1.04
Humans have antibodies against a plant virus: evidence from tobacco mosaic virus. PLoS One (2013) 1.00
Calcium channel blockers and beta-blockers in relation to Parkinson's disease. Parkinsonism Relat Disord (2006) 1.00
Green tea polyphenols and their potential role in health and disease. Inflammopharmacology (2015) 0.98
Flavonoid-based therapies in the early management of neurodegenerative diseases. Adv Nutr (2015) 0.93
Tea and human health: biomedical functions of tea active components and current issues. J Zhejiang Univ Sci B (2015) 0.91
Neuroprotective effects of resveratrol and epigallocatechin gallate polyphenols are mediated by the activation of protein kinase C gamma. Front Cell Neurosci (2013) 0.91
Environmental tobacco smoke and Parkinson's disease. Mov Disord (2011) 0.91
Alpha-synuclein, alcohol use disorders, and Parkinson disease: a case-control study. Parkinsonism Relat Disord (2009) 0.90
Effects of parkinsonism on health status in welding exposed workers. Parkinsonism Relat Disord (2011) 0.89
Coffee, caffeine-related genes, and Parkinson's disease: a case-control study. Mov Disord (2008) 0.89
Epigallocatechin-3-gallate: a useful, effective and safe clinical approach for targeted prevention and individualised treatment of neurological diseases? EPMA J (2013) 0.89
LINE-1 DNA methylation, smoking and risk of Parkinson's disease. J Parkinsons Dis (2012) 0.88
Nutraceuticals in cognitive impairment and Alzheimer's disease. Front Pharmacol (2014) 0.87
Lack of replication of the GRIN2A-by-coffee interaction in Parkinson disease. PLoS Genet (2014) 0.86
Dealing with misfolded proteins: examining the neuroprotective role of molecular chaperones in neurodegeneration. Molecules (2010) 0.86
Association between Parkinson's Disease and Cigarette Smoking, Rural Living, Well-Water Consumption, Farming and Pesticide Use: Systematic Review and Meta-Analysis. PLoS One (2016) 0.85
Lower plasma apolipoprotein A1 levels are found in Parkinson's disease and associate with apolipoprotein A1 genotype. Mov Disord (2014) 0.84
Exploring the nexus of Alzheimer's disease and related dementias with cancer and cancer therapies: A convening of the Alzheimer's Association & Alzheimer's Drug Discovery Foundation. Alzheimers Dement (2016) 0.83
Medicinal chemistry of the epigenetic diet and caloric restriction. Curr Med Chem (2013) 0.83
Genotype and age at Parkinson disease diagnosis. Int J Mol Epidemiol Genet (2013) 0.83
Potential neuroprotective properties of epigallocatechin-3-gallate (EGCG). Nutr J (2016) 0.81
Dietary factors in the etiology of Parkinson's disease. Biomed Res Int (2015) 0.81
Gender differences in the effect of tobacco use on brain phosphocreatine levels in methamphetamine-dependent subjects. Am J Drug Alcohol Abuse (2015) 0.81
Risk factors for probable REM sleep behavior disorder: A community-based study. Neurology (2016) 0.81
Alcohol drinking and risk of Parkinson's disease: a case-control study in Japan. BMC Neurol (2010) 0.80
A study on risk factors for Parkinson׳s disease in Indian population. Bioinformation (2014) 0.80
Oxidative Stress and Inflammation: What Polyphenols Can Do for Us? Oxid Med Cell Longev (2016) 0.80
Lifestyle, family history, and risk of idiopathic Parkinson disease: a large Danish case-control study. Am J Epidemiol (2015) 0.79
Association mapping of the PARK10 region for Parkinson's disease susceptibility genes. Parkinsonism Relat Disord (2013) 0.79
Flavanols, mild cognitive impairment, and Alzheimer's dementia. Int J Clin Exp Med (2008) 0.79
Alcohol Consumption and Parkinson's Disease Risk: A Review of Recent Findings. J Parkinsons Dis (2015) 0.78
Stuck at the bench: Potential natural neuroprotective compounds for concussion. Surg Neurol Int (2011) 0.78
Parkinson's disease and history of outdoor occupation. Parkinsonism Relat Disord (2013) 0.78
Co-morbidities of persons dying of Parkinson's disease. Prog Palliat Care (2013) 0.77
The PROMESA-protocol: progression rate of multiple system atrophy under EGCG supplementation as anti-aggregation-approach. J Neural Transm (Vienna) (2016) 0.76
A meta-analysis of tea drinking and risk of Parkinson's disease. ScientificWorldJournal (2012) 0.76
Formulations of hormone therapy and risk of Parkinson's disease. Mov Disord (2014) 0.76
Can Tea Consumption be a Safe and Effective Therapy Against Diabetes Mellitus-Induced Neurodegeneration? Curr Neuropharmacol (2014) 0.76
hVMAT2: A Target of Individualized Medication for Parkinson's Disease. Neurotherapeutics (2016) 0.75
Can coffee consumption lower the risk of Alzheimer's disease and Parkinson's disease? A literature review. Arch Med Sci (2016) 0.75
Interaction of methamphetamine abuse, tobacco abuse, and gender in the brain. Am J Drug Alcohol Abuse (2015) 0.75
Nutrition and the risk for Parkinson's disease: review of the literature. J Neural Transm (Vienna) (2008) 0.75
Common variation in the LRRK2 gene is a risk factor for Parkinson's disease. Mov Disord (2012) 0.75
Development of interspecific Solanum lycopersicum and screening for Tospovirus resistance. Saudi J Biol Sci (2014) 0.75
A predictive model to identify Parkinson disease from administrative claims data. Neurology (2017) 0.75
Therapies for Parkinson's diseases: alternatives to current pharmacological interventions. J Neural Transm (Vienna) (2016) 0.75
Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature (2011) 13.25
Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA (2010) 9.52
Validating administrative data in stroke research. Stroke (2002) 5.90
Genomewide association studies of stroke. N Engl J Med (2009) 5.29
Home use of automated external defibrillators for sudden cardiac arrest. N Engl J Med (2008) 4.64
Clinical practice guidelines for support of the family in the patient-centered intensive care unit: American College of Critical Care Medicine Task Force 2004-2005. Crit Care Med (2007) 4.14
Incidental findings on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ (2009) 3.91
Cognitive impairment and decline are associated with carotid artery disease in patients without clinically evident cerebrovascular disease. Ann Intern Med (2004) 3.66
The clinical efficacy of magnetic resonance imaging in neuroimaging. Ann Intern Med (1994) 3.33
Prognosis in amyotrophic lateral sclerosis: a population-based study. Neurology (2003) 3.14
Withdrawal of support in intracerebral hemorrhage may lead to self-fulfilling prophecies. Neurology (2001) 3.07
The association of antihypertensive agents with MRI white matter findings and with Modified Mini-Mental State Examination in older adults. J Am Geriatr Soc (1997) 2.98
Aspartame ingestion and headaches: a randomized crossover trial. Neurology (1994) 2.91
Midlife and late-life obesity and the risk of dementia: cardiovascular health study. Arch Neurol (2009) 2.79
Neighborhood socioeconomic disadvantage and mortality after stroke. Neurology (2013) 2.74
Silent MRI infarcts and the risk of future stroke: the cardiovascular health study. Neurology (2001) 2.55
White matter hyperintensity on cranial magnetic resonance imaging: a predictor of stroke. Stroke (2004) 2.50
Genome-wide association studies of cerebral white matter lesion burden: the CHARGE consortium. Ann Neurol (2011) 2.37
Elevated risk of stroke among patients with end-stage renal disease. Kidney Int (2003) 2.35
Antihypertensive drug therapies and the risk of ischemic stroke. Arch Intern Med (2001) 2.24
Pilot randomized clinical trial of prehospital induction of mild hypothermia in out-of-hospital cardiac arrest patients with a rapid infusion of 4 degrees C normal saline. Circulation (2007) 2.18
Factor V Leiden (resistance to activated protein C) increases the risk of myocardial infarction in young women. Blood (1997) 2.15
Sulcal, ventricular, and white matter changes at MR imaging in the aging brain: data from the cardiovascular health study. Radiology (1997) 2.13
Nicotine from edible Solanaceae and risk of Parkinson disease. Ann Neurol (2013) 2.08
Prospective study of alcohol consumption and risk of dementia in older adults. JAMA (2003) 1.98
Alcohol use and risk of ischemic stroke among older adults: the cardiovascular health study. Stroke (2005) 1.94
White matter grade and ventricular volume on brain MRI as markers of longevity in the cardiovascular health study. Neurobiol Aging (2006) 1.88
Cystatin C and subclinical brain infarction. J Am Soc Nephrol (2005) 1.88
Risk factors for intracerebral hemorrhage in a pooled prospective study. Stroke (2007) 1.84
Common variants at 6p21.1 are associated with large artery atherosclerotic stroke. Nat Genet (2012) 1.81
Common variants at 12q14 and 12q24 are associated with hippocampal volume. Nat Genet (2012) 1.79
Vascular events, mortality, and preventive therapy following ischemic stroke in the elderly. Neurology (2005) 1.76
Gait variability is associated with subclinical brain vascular abnormalities in high-functioning older adults. Neuroepidemiology (2007) 1.74
Occupational exposures and amyotrophic lateral sclerosis. A population-based case-control study. Am J Epidemiol (1997) 1.73
Association of cholesterol with stroke risk varies in stroke subtypes and patient subgroups. Neurology (2004) 1.72
Atrial fibrillation and cognitive decline: a longitudinal cohort study. Neurology (2013) 1.71
Do-not-attempt-resuscitation orders and prognostic models for intraparenchymal hemorrhage. Crit Care Med (2011) 1.67
Parkinson's disease risks associated with dietary iron, manganese, and other nutrient intakes. Neurology (2003) 1.66
Prediction of awakening after out-of-hospital cardiac arrest. N Engl J Med (1983) 1.58
Clinically serious abnormalities found incidentally at MR imaging of the brain: data from the Cardiovascular Health Study. Radiology (1997) 1.57
Active surface cooling protocol to induce mild therapeutic hypothermia after out-of-hospital cardiac arrest: a retrospective before-and-after comparison in a single hospital. Crit Care Med (2009) 1.54
Cholesterol reduction and the risk for stroke in men. A meta-analysis of randomized, controlled trials. Ann Intern Med (1993) 1.53
Proxy respondents in epidemiologic research. Epidemiol Rev (1990) 1.51
Common variants at 6q22 and 17q21 are associated with intracranial volume. Nat Genet (2012) 1.51
Completeness and accuracy of interview data from proxy respondents: demographic, medical, and life-style factors. Epidemiology (1994) 1.49
Biomarkers of Inflammation and MRI-Defined Small Vessel Disease of the Brain: The Cardiovascular Health Study. Stroke (2008) 1.48
Pesticides and risk of Parkinson disease: a population-based case-control study. Arch Neurol (2005) 1.47
Incidence of amyotrophic lateral sclerosis in three counties in western Washington state. Neurology (1996) 1.47
Gain-of-function ADCY5 mutations in familial dyskinesia with facial myokymia. Ann Neurol (2014) 1.47
Genome-wide association studies of MRI-defined brain infarcts: meta-analysis from the CHARGE Consortium. Stroke (2009) 1.47
Alcohol consumption and risk of coronary heart disease in older adults: the Cardiovascular Health Study. J Am Geriatr Soc (2006) 1.46
Hypertension and cognitive function: pathophysiologic effects of hypertension on the brain. Curr Hypertens Rep (2003) 1.44
Cerebrospinal fluid creatine kinase-BB isoenzyme activity and outcome after subarachnoid hemorrhage. Arch Neurol (1999) 1.44
Multidisciplinary pain center outcomes in Washington State Workers' Compensation. J Occup Environ Med (2004) 1.43
Active and passive smoking and risk of narcolepsy in people with HLA DQB1*0602: a population-based case-control study. Neuroepidemiology (2008) 1.43
Somatosensory potentials, CSF creatine kinase BB activity, and awakening after cardiac arrest. Neurology (2000) 1.42
A communitywide intervention to improve outcomes and reduce disability among injured workers in Washington State. Milbank Q (2004) 1.41
When you look for evidence and find too much: systematic reviews to the rescue. Neurology (1998) 1.41
Cerebrospinal fluid creatine kinase BB isoenzyme activity and neurologic prognosis after cardiac arrest. Neurology (1997) 1.41
Population-based case-control study of amyotrophic lateral sclerosis in western Washington State. I. Cigarette smoking and alcohol consumption. Am J Epidemiol (2000) 1.36
Assessment of occupational exposures in community-based case-control studies. Annu Rev Public Health (1998) 1.35
Fish consumption and stroke risk in elderly individuals: the cardiovascular health study. Arch Intern Med (2005) 1.35
Diabetes, smoking, and other medical conditions in relation to Parkinson's disease risk. Parkinsonism Relat Disord (2005) 1.32
Pilot study of rapid infusion of 2 L of 4 degrees C normal saline for induction of mild hypothermia in hospitalized, comatose survivors of out-of-hospital cardiac arrest. Circulation (2005) 1.29
Antihypertensive treatment with ACE inhibitors or beta-blockers and risk of incident atrial fibrillation in a general hypertensive population. Am J Hypertens (2009) 1.27
Nonsteroidal anti-inflammatory drugs and risk of Parkinson's disease. Mov Disord (2006) 1.27
Shortening the NIH Stroke scale for use in the prehospital setting. Stroke (2002) 1.27
Lumbar fusion outcomes in Washington State workers' compensation. Spine (Phila Pa 1976) (2006) 1.26
Measures of adiposity and future risk of ischemic stroke and coronary heart disease in older men and women. Am J Epidemiol (2010) 1.26
Occupational factors and risk of Parkinson's disease: A population-based case-control study. Am J Ind Med (2010) 1.26
AAN clinical practice guidelines: above the fray. Neurology (2002) 1.24
Diuretic therapy, the alpha-adducin gene variant, and the risk of myocardial infarction or stroke in persons with treated hypertension. JAMA (2002) 1.23
Subarachnoid hemorrhage and family history. A population-based case-control study. Arch Neurol (1995) 1.22
Hormone replacement therapy and associated risk of stroke in postmenopausal women. Arch Intern Med (2002) 1.22
Hearing loss and antiretroviral therapy in patients infected with HIV-1. Arch Neurol (1997) 1.21
Recursive partitioning for the identification of disease risk subgroups: a case-control study of subarachnoid hemorrhage. J Clin Epidemiol (1998) 1.20
Education and the cognitive decline associated with MRI-defined brain infarct. Neurology (2006) 1.20
Hospitalization for infection and risk of acute ischemic stroke: the Cardiovascular Health Study. Stroke (2011) 1.18
Increased reporting of occupational hearing loss: workers' compensation in Washington State, 1984-1998. Am J Ind Med (2002) 1.17
Neurologic recovery after out-of-hospital cardiac arrest. Ann Intern Med (1983) 1.16
Hormonal exposures and the risk of intracranial meningioma in women: a population-based case-control study. BMC Cancer (2006) 1.16
Validity study of self-reported pesticide exposure among orchardists. J Expo Anal Environ Epidemiol (2001) 1.16
Increased pelvic vein thrombi in cryptogenic stroke: results of the Paradoxical Emboli from Large Veins in Ischemic Stroke (PELVIS) study. Stroke (2003) 1.16
Work-related carpal tunnel syndrome in Washington State workers' compensation: utilization of surgery and the duration of lost work. Am J Ind Med (2009) 1.12